Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1551 of 5804
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-101/GI-101A as a single agent or in combination with pembrolizumab or lenvatinib over a range of advanced and/or metastatic solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a new pill calm Autism-Related irritability?
Symptom relief CompletedThe purpose of this study is to establish the potential benefits, safety, and tolerability of AB-2004 in participants with irritability associated with autism spectrum disorder.
Phase: PHASE2 • Sponsor: Vertero Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Diabetes duo: new combo shot shows promise for blood sugar
Disease control CompletedThis study looks at how well a new medicine called cagrilintide works together with semaglutide on blood sugar levels in people with type 2 diabetes compared to cagrilintide alone or semaglutide alone. Before a new medicine can be prescribed to people it needs to be tested to se…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New needle technique may spare breast cancer patients from surgery
Disease control CompletedThis study will assess whether it is feasible to remove small breast cancers completely using the Vacuum Assisted Biopsy (VAB) system System under Ultrasound guidance.
Phase: NA • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Brain bleed breakthrough? new procedure aims to stop clots from returning
Disease control OngoingEMMA-Can is a prospective randomized open-label, blinded end point (PROBE) study, that will assess the recurrence risk and safety of embolization of the middle meningeal (EMMA) when added to standard of care treatment (surgical drainage) of chronic subdural hematoma (CSDH) compar…
Phase: NA • Sponsor: University of Manitoba • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Robot and electrical zaps at home could boost stroke recovery
Disease control Recruiting nowThe investigators have developed a novel robot-guided stretching under intelligent control and combine it with active movement training, which helped increase joint ROM, reduce spasticity and joint stiffness, increase muscle force output, and improve locomotion. However, for stro…
Phase: PHASE1, PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Experimental drug combo targets tough bone cancer
Disease control CompletedThis is a phase 1/2 study of azenosertib (ZN-c3) in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.
Phase: PHASE1 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Light therapy shows promise for Schizophrenia's toughest symptoms
Symptom relief CompletedAbstract: Randomized clinical trial that aims to see the efficacy of photoneuromodulation for the treatment of negative symptoms of schizophrenia in patients refractory to transcranial direct current stimulation. In this group of 30 refractory volunteers, magnetic resonance spect…
Phase: PHASE2 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Muscle relaxants may boost oxygen in severe COVID-19 lung failure
Disease control CompletedMany questions about management of COVID-19 are still not answered. So, we recruit this study aiming to evaluate improvement of oxygenation in COVID-19 patients with severe ARDS, to improve morbidity and mortality of ICU covid patients, to participate in understanding of real hid…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New inhaled therapy aims to ease lung blood pressure
Disease control OngoingThis Phase 3, 2-part, open-label, multicenter study aims to demonstrate the safety and tolerability of L606 in patients with PAH or PH-ILD. The study will determine the short-term and long-term safety and tolerability of L606 in this patient population.
Phase: PHASE3 • Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo therapy aims to keep lymphoma at bay after transplant
Disease control Recruiting nowPatients will receive one of two conditioning regimens (BEAM or CBV) before receiving an autologous stem cell transplant (ASCT). If patients achieve either complete, partial, or stable response following ASCT, they will receive an IV dose of Polatuzumab Vedotin once every 21 days…
Phase: PHASE1, PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Healing after loss: can talk therapy lift depression?
Symptom relief CompletedThis study tests the efficacy of interpersonal psychotherapy (IPT) for major depression following perinatal loss (early and late fetal death and early neonatal death) in a sample of 274 women in Flint and Detroit, Michigan. The trial will be the first fully powered randomized tri…
Phase: NA • Sponsor: Michigan State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug duo aims to control returning lymphoma
Disease control Recruiting nowThis phase 2 trial studies the efficacy and safety of orelabrutinib plus rituximab followed by maintenance with orelabrutinib for relapsed and refractory follicular lymphoma(RR FL)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can zapping two brain areas beat OCD?
Disease control Recruiting nowThe purpose of this study is to identify abnormal brain signals associated with Obsessive Compulsive Disorder (OCD) and psychiatric symptoms and to investigate novel therapeutic stimulation sites. While treating OCD with standard deep brain stimulation (DBS) therapy, the investig…
Phase: NA • Sponsor: Andrew Moses Lee, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
No-Needle liver test: MRI may replace painful biopsies
Diagnosis CompletedChronic liver disease is a major healthcare problem in Hong Kong and worldwide. The diagnosis of liver fibrosis and inflammation in patients with chronic liver disease has important prognostic and therapeutic implications. The current gold standard to evaluate and stage the sever…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Antibody therapy shields vulnerable patients from severe COVID-19
Disease control CompletedAbsence of anti-SARS-CoV-2 vaccine response or insufficient vaccine response may occur in immunocompromised patients. Being at high risk of a severe form of Covid-19, they may be eligible to receive recombinant anti-SARS-CoV-2 monoclonal antibodies (mAbs). This study aims to desc…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Hypnosis may ease Chemotherapy's toll on breast cancer patients
Symptom relief OngoingThis study is a randomized controlled trial, taking place at the University Hospital Basel (CH). It aims at the alleviation of breast cancer patients' life quality during chemotherapy. The intervention group will participate in 10 sessions of structured hypnotherapy during the c…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New pill could tame tough eczema
Disease control CompletedThis is a Phase II, randomized, double-blind, placebo-controlled study in subjects with moderate to severe atopic dermatitis.
Phase: PHASE2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Brain cancer vaccine shows promise in early trial
Disease control CompletedThis is a single-center, single-arm phase I study to determine the safety and preliminary efficacy of autologous dendritic cells (DCs) loaded with multiple tumor neoantigen peptides administered as a cancer-treatment vaccine to treat adult postoperative patients with newly-diagno…
Phase: PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail aims to tackle Hard-to-Treat myeloma
Disease control OngoingThe primary purpose is to determine the safety and tolerability of belantamab mafodotin in combination with isatuximab, and to establish the recommended Phase 2 dose (RP2D) for the combination treatment to explore in the cohort expansion (CE) phase in participants with RRMM. This…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC